يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"Bover, Jordi"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Raggi,P Division of Cardiology and Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Bellasi,A Research, Innovation and Brand Reputation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy. Sinha,S Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, United Kingdom. Bover,J Department of Nephrology, Fundació Puigvert and Universitat Autònoma, IIB Sant Pau, REDinREN, Barcelona, Spain. Rodriguez,M Nephrology Unit, Hospital Universitario Reina Sofia, IMIBIC, REDinREN, Córdoba, Spain. Ketteler,M Department of General Internal Medicine and Nephrology, Robert-Bosch-Krankenhaus, Stuttgart, Germany. Bushinsky,DA Department of Medicine, University of Rochester School of Medicine, Rochester, New York, USA. Garg,R PharmaDRS, LLC, San Diego, California, USA. Perelló,J Research and Development, Sanifit Therapeutics, Palma, Spain. Perelló,J University of the Balearic Islands, Palma, Spain. Gold,A Research and Development, Sanifit Therapeutics, San Diego, California, USA. Gold,A, Chertow,GM Department of Medicine, Stanford University, Palo Alto, California, USA., This work was supported by Sanifit Therapeutics, S.A.

    مصطلحات موضوعية: Coronary calcification, Vascular calcification, Hemodialysis, Calcificación vascular, Diálisis renal, Enfermedades Renales, SNF472, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Medical Subject Headings::Chemicals and Drugs::Biological Factors::Blood Coagulation Factors::Calcium, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Lipid Regulating Agents::Hypolipidemic Agents::Anticholesteremic Agents::Hydroxymethylglutaryl-CoA Reductase Inhibitors, Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Pyrans::Benzopyrans::Coumarins::4-Hydroxycoumarins::Warfarin, Medical Subject Headings::Anatomy::Cardiovascular System::Blood Vessels::Arteries::Coronary Vessels, Medical Subject Headings::Diseases::Cardiovascular Diseases, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Chemistry Techniques, Analytical::Crystallization, Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Epidemiologic Study Characteristics as Topic::Clinical Trials as Topic::Controlled Clinical Trials as Topic::Randomized Controlled Trials as Topic::Intention to Treat Analysis, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Renal Replacement Therapy::Renal Dialysis, Medical Subject Headings::Chemicals and Drugs::Inorganic Chemicals::Phosphorus Compounds::Phosphorus Acids::Phosphoric Acids::Phosphates, Medical Subject Headings::Diseases::Endocrine System Diseases::Diabetes Mellitus, Medical Subject Headings::Chemicals and Drugs::Inorganic Chemicals::Calcium Compounds::Calcium Phosphates::Apatites::Hydroxyapatites, Medical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Steroids::Secosteroids::Vitamin D

    وصف الملف: application/pdf

    العلاقة: https://www.sciencedirect.com/science/article/pii/S2468024920315485?via%3DihubTest; Raggi P, Bellasi A, Sinha S, Bover J, Rodriguez M, Ketteler M, et al. Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO Trial. Kidney Int Rep. 2020 Nov 4;5(12):2178-2182; http://hdl.handle.net/10668/3550Test; PMC7710828

  2. 2
    دورية أكاديمية
  3. 3
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
  9. 9
    دورية أكاديمية
  10. 10